Skip to content

Moothanda thailam (nasiyam) for peenisam (sinusitis)

An open single arm clinical trial to determine the therapeutic effect of moothanda thailam (nasiyam) in the management of peenisam (sinusitis) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069522
Enrollment
10
Registered
2024-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J019- Acute sinusitis, unspecified

Interventions

Intervention1: Moothanda thailam: Nasal drops-3 drops in each nostril once a day for 10 continuous days Control Intervention1: NIL: NIL

Sponsors

National institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from acute and recurrent acute sinusitis. Patients having signs and symptoms of Sneezing, Running nose, Nasal congestion, Post nasal discharge, Cough, Thick nasal discharge, Facial pain or Pressure, Watery eyes, Head ache, Ear fullness, Hyposmia, Dental pain (More than 3 clinical symptoms will be included for the study).

Exclusion criteria

Exclusion criteria: History of Nasal polyp History of Bronchial asthma Participants with fever Pregnant women Participants with evidence of malignancy Participants with any other serious systemic illness

Design outcomes

Primary

MeasureTime frame
it is assessed by Sino nasal outcome test -22(SNOT -22)Timepoint: study period 6 months Treatment duration 10 days

Secondary

MeasureTime frame
changes in lab parametersTimepoint: study period 6 months Treatment duration 10 days

Countries

India

Contacts

Public ContactDr Mahadevan M V

National Institute of Siddha

mvmresearch2008@gmail.com9840417565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026